东地中海人群中心血管预防的最佳睡眠时间:从前性队列研究的见解
Danial Habibi1, Maryam Kazemi Naeini2, Shaghyegh Haghjooy Javanmard3
1Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
BMC cardiovascular disorders
|December 16, 2025
概括
对心血管健康的最佳睡眠时间可能因地区而异. 这项研究发现,每天大约8.4小时的睡眠与伊朗人口中心血管疾病 (CVD) 风险最低程度有关.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 流行病学 流行病学
背景情况:
- 心血管疾病 (CVD) 在全球范围内对健康造成重大负担.
- 睡眠时间和心血管疾病风险之间的关系是复杂的,并且在不同人群中可能有所不同.
- 确定最佳睡眠模式对于公共卫生战略至关重要.
研究的目的:
- 为了确定东地中海地区 (EMR) 的健康人口的睡眠时间轨迹.
- 调查已识别的睡眠模式与心血管疾病 (CVD) 发生率之间的关联.
主要方法:
- 一项前性,基于人口的队列研究,涉及5,432名没有先前心血管疾病的参与者.
- 分析睡眠时间轨迹及其与发生心血管疾病的相关性,使用多变量Cox比例危险模型.
- 应用立方体和受限制的立方体线条模型来确定最佳睡眠时间,以尽量减少心血管疾病风险.
主要成果:
- 在每日总睡眠时间和发生心血管疾病之间观察到U形的关联.
- 在睡眠时间约为8.4小时时,发现心血管疾病风险最低.
- 睡眠时间在6-7小时 (HR=0.772) 和8-9小时 (HR=0.701) 之间,心血管疾病风险显著降低,而睡眠时间在5小时以下.
结论:
- 国际上推的睡眠时间可能不是普遍最佳的.
- 每天大约8.4小时的睡眠与被研究的伊朗人群中最低的心血管疾病风险有关.
- 研究结果表明,对于心血管健康来说,理想的睡眠时间可能存在区域差异.
相关概念视频
Insufficient Sleep and Sleep Deprivation
805
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
805
Coronary Artery Disease IV: Preventive Measures
572
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
331
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
331
Substance Use Disorders Affecting Sleep
366
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
366
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Hypertension IV: Drug Therapy and Lifestyle Modifications
575
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
575


